Juan F. Gallardo-Medina

Sevilla, AN 41013, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Effect of Delayed Initiation of Mepolizumab on EXACTO Scale Scores, Clinical Remission SEPAR-REMAS Criteria, and Functional Outcomes in Uncontrolled Severe Asthma: A Real-World Study.

Effect of Delayed Initiation of Mepolizumab on EXACTO Scale Scores, Clinical Remission SEPAR-REMAS Criteria, and Functional Outcomes in Uncontrolled Severe Asthma: A Real-World Study.

Journal: Medical sciences (Basel, Switzerland)

Published: May 31, 2026

Long-Term Adherence to Benralizumab and Sustained Clinical Benefits in Patients with Severe Eosinophilic Asthma: Insights from GALERNA, a Retrospective Real-World Study in Spain.

Long-Term Adherence to Benralizumab and Sustained Clinical Benefits in Patients with Severe Eosinophilic Asthma: Insights from GALERNA, a Retrospective Real-World Study in Spain.

Journal: Journal of clinical medicine

Published: May 15, 2026

Clinical Utility of Oscillometry for Assessing Pulmonary Function in Asthmatic Pregnant Women With Contraindications to Spirometry.

Clinical Utility of Oscillometry for Assessing Pulmonary Function in Asthmatic Pregnant Women With Contraindications to Spirometry.

Journal: Archivos de bronconeumologia

Published: January 23, 2026

Monitoring Lung Function of Asthmatic Swimmers in Public Swimming Pools.

Monitoring Lung Function of Asthmatic Swimmers in Public Swimming Pools.

Journal: Open respiratory archives

Published: December 30, 2025

Effectiveness of Mepolizumab in Severe Uncontrolled Asthma Associated or Not with EGPA Based on the Exacto Scale and Separ-Remas Criteria.

Effectiveness of Mepolizumab in Severe Uncontrolled Asthma Associated or Not with EGPA Based on the Exacto Scale and Separ-Remas Criteria.

Journal: Journal of asthma and allergy

Published: October 05, 2025

Effectiveness of Mepolizumab and Dupilumab in patients with asthma-COPD overlap (ACO) compared to severe uncontrolled asthma (SUA): A retrospective observational cohort study.

Effectiveness of Mepolizumab and Dupilumab in patients with asthma-COPD overlap (ACO) compared to severe uncontrolled asthma (SUA): A retrospective observational cohort study.

Journal: Pulmonary pharmacology & therapeutics

Published: August 19, 2025

Cost-utility study of a high-resolution consultation (CARE-A) for the treatment of asthma exacerbations

Cost-utility study of a high-resolution consultation (CARE-A) for the treatment of asthma exacerbations

Journal: Open respiratory archives

Published: July 16, 2025

Clinical and epidemiological characteristics of nontuberculous mycobacteria pulmonary infections in the healthcare area of Virgen del Rocío University Hospital in Seville (2020-2023).

Clinical and epidemiological characteristics of nontuberculous mycobacteria pulmonary infections in the healthcare area of Virgen del Rocío University Hospital in Seville (2020-2023).

Journal: Enfermedades infecciosas y microbiologia clinica (English ed.)

Published: April 24, 2025

FEV1 decline and clinical predictors in asthma after 10 Years of follow-up: BMI as a modifiable risk factor.

FEV1 decline and clinical predictors in asthma after 10 Years of follow-up: BMI as a modifiable risk factor.

Journal: Respiratory medicine

Published: April 20, 2025

Identification of Fractional Exhaled Nitric Oxide Cutoff Values for the Diagnosis of Asthma.

Identification of Fractional Exhaled Nitric Oxide Cutoff Values for the Diagnosis of Asthma.

Journal: Archivos de bronconeumologia

Published: January 18, 2025

Multicentre controlled open randomised clinical trial to assess efficacy and safety of an anti-tuberculosis drug combination based on optimised-dose rifampicin, optimised-dose moxifloxacin and optimised-dose linezolid for TB: the RML-TB trial protocol.

Multicentre controlled open randomised clinical trial to assess efficacy and safety of an anti-tuberculosis drug combination based on optimised-dose rifampicin, optimised-dose moxifloxacin and optimised-dose linezolid for TB: the RML-TB trial protocol.

Journal: BMJ open respiratory research

Published: April 03, 2024

Evaluation of the Diagnostic Accuracy of Non-Specific Bronchial Provocation Tests in the Diagnosis of Asthma: A Randomized Cross-Over Study.

Evaluation of the Diagnostic Accuracy of Non-Specific Bronchial Provocation Tests in the Diagnosis of Asthma: A Randomized Cross-Over Study.

Journal: Archivos de bronconeumologia

Published: July 24, 2022

Showing 1-12 of 18

Last Updated: 09/26/2026